He had a CT scan of his abdomen that revealed a mass measuring approximately 7 cm x 7 cm x 8 cm as well as several liver masses consistent with metastases.
In mid [**Month (only) 205**], he underwent a CT-guided biopsy showing neuroendocrine tumor and these were also seen on a PET scan identifying the mass in the pancreas and lymphatic involvement of the celiac trunk as well as FDG uptake in several of the liver lesions.
Extr: Warm, no c/c/e   Pertinent Results: [**2190-10-6**] 06:15AM BLOOD WBC-14.7* RBC-3.25* Hgb-9.6* Hct-27.5* MCV-85 MCH-29.6 MCHC-34.9 RDW-14.5 Plt Ct-643* [**2190-10-5**] 06:40AM BLOOD Glucose-146* UreaN-15 Creat-1.1 Na-140 K-3.6 Cl-102 HCO3-28 AnGap-14 [**2190-10-5**] 06:40AM BLOOD ALT-54* AST-28 AlkPhos-74 TotBili-0.5 [**2190-10-5**] 06:40AM BLOOD Calcium-8.5 Phos-3.2 Mg-1.8 [**2190-10-5**] 06:05PM ASCITES Amylase-22                           Pathology Examination Name Birthdate    Age     Sex Pathology #     [**Hospital1 18**] [**Known lastname 91523**],[**Known firstname 20**]       [**2136-11-24**]    53 Male      [**-1/3805**] [**Numeric Identifier 91524**] Report to:   DR. [**Last Name (STitle) **] [**Last Name (NamePattern4) **] Gross Description by:   DR. [**Last Name (STitle) **] [**Last Name (NamePattern4) 88622**]/dif  SPECIMEN SUBMITTED: omentum and spleen, Body and tail of pancreas, antrum, pancreatic tumor, gall bladder, Segment three resection, Segment three hamartoma, Segment two and three.
Antrum, distal gastrectomy (Q-V): Unremarkable stomach with antral mucosa; no tumor seen.
Mitotic activity:  Less than 2 mitoses/10 High Power Fields.
Intraoperatively, the patient received 2 units of RBC and 2 units of FFP for EBL 1100, he was hemodynamically stable.
They thought to be secondary to his diagnosis, treatment continuation and possible outcomes.
Pulmonary: The patient remained stable from a pulmonary standpoint; vital signs were routinely monitored.
JP amylase was sent on POD # 7 and came back low (22).
ID: The patient's white blood count and fever curves were closely watched for signs of infection.
The patient was instructed to follow up with his PCP to continue monitor his blood sugar and further treatment plans.
Hematology: The patient had a base line HCT level of 43.7 preop.
His HCT dropped to 29.8 intraoperatively and patient received transfusion 2 units of RBC.
Postoperatively HCT was checked daily and on POD # 4 was low at 20.6.
Please follow up with Dr. [**Last Name (STitle) **] (PCP) in [**2-18**] weeks after discharge to continue monitor your blood sugar.
